Early research (Phase 1)Study completedNCT03881488
What this trial is testing
Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies
Who this might be right for
Locally Advanced Solid TumorMetastatic CancerNon-small Cell Lung Cancer+4 more
Compass Therapeutics 100